Theralase Technologies Inc. V.TLT

Serious spike in market valuation ahead if

[ScienceFirst]

If TLD1433 delivers on both oncology (pivotal NMIBC Ph. 2) and vaccine (enveloped viruses like COVID-19, influenza, Zika, herpes simplex, MonkeyPox, shingle, etc ...), and that we are granted FDA Breakthrough designation and Accelerated Approval (that would allow us to receive revenues from the remaining patients enrolling in our Ph. 2), then we land on the radar of big pharmas, without any doubt. 

For sure, the credibility of NML will de facto capture the interest of big pharmas as it will be a validation from a 3rd party that has worldwide expertise and knowhow.

And regarding the NMIBC indication, our 2 main competitors are combos and they require many treatments.  

We would get credibility on both markets!  You rarely see that.

[Legit62]

SF, my feeling is we are on the radar with this new technology, its that they are just waiting for further data and it would be a no brainer to try and partner up. The issue i have is i hope we dont sell ourselves short. This company with its cancer txs and vaccine on the way could very well be worth billions, im sure management knows this after this long wait

[Eoganacht]

I'm pretty sure they know. Otherwise, why would Roger and Kristina spend $225,000.exercising 750,000 warrants at 30 cents back in May?

[Oilminerdeluxe]

Here's to a similar move tomorrow... if so, well, happy days.

[ScienceFirst]

I agree Eoganacht.  That was a clear signal to us that summed up everything. I would also add that when TLT put out the Feb. 7 news release, they already had a confirmation about the efficacy of TLD-1433 in the in-vitro (the 99.99%) and they already had discussed with NML's Dr. Kobasa about the chances of success for the last preclinical step and the additional knowhow that NML brought

[FGPstock]

Great to finally see some action, and mostly all buying. What is everyone expecting at the end of the month. I thought BTD was scheduled for 4th q.

[pullsea]

could it not be simply a recovery as the mkt sentiment has been improving?

[ScienceFirst]

Legit62 ... Roger is a fierce negociator.  He also has 8M shares.  He brought this from scratch, enduring obstacles.  Bet on him that he won settle for less.   A negociation is always to your advantage when you have many interested parties.  A bidding war is always in one's favor.  One thing's for sure, all of this will rely on clinical data.